About VenoStent
VenoStent is a company based in Nashville (United States) founded in 2017.. VenoStent has raised $23.36 million across 11 funding rounds from investors including NIH, HHS and Norwest Venture Partners. VenoStent offers products and services including SelfWrap. VenoStent operates in a competitive market with competitors including Invizius, Renal Solutions, Redsense Medical, Doto Medical and Health Line International Corporation, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Venostent, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.36 M (USD)
in 11 rounds
-
Latest Funding Round
-
Investors
NIH
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VenoStent
VenoStent offers a comprehensive portfolio of products and services, including SelfWrap. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioabsorbable wrap designed to prevent failures in dialysis access sites.
Unlock access to complete
Unlock access to complete
Funding Insights of VenoStent
VenoStent has successfully raised a total of $23.36M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Last Round
-
First Round
First Round
(07 Mar 2018)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2026 | Amount | Series A - VenoStent | Valuation |
investors |
|
| Jun, 2024 | Amount | Grant - VenoStent | Valuation |
investors |
|
| Jun, 2024 | Amount | Series A - VenoStent | Valuation | Good Growth Capital , IAG Capital Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VenoStent
VenoStent has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Norwest Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in life sciences and technologies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VenoStent
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - VenoStent
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Venostent Comparisons
Competitors of VenoStent
VenoStent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invizius, Renal Solutions, Redsense Medical, Doto Medical and Health Line International Corporation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Priming solutions for hemodialyzers are developed to reduce blood reactions.
|
|
| domain | founded_year | HQ Location |
Sorbents for renal replacement therapy are developed using regenerative technology.
|
|
| domain | founded_year | HQ Location |
Blood access is monitored during hemodialysis via alarm systems.
|
|
| domain | founded_year | HQ Location |
Develops medical devices to enhance hemodialysis and treat kidney disease.
|
|
| domain | founded_year | HQ Location |
Contract Manufacturer of Dialysis products, Also sells own product lines.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Venostent
Frequently Asked Questions about VenoStent
When was VenoStent founded?
VenoStent was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is VenoStent located?
VenoStent is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Who is the current CEO of VenoStent?
Timothy Boire is the current CEO of VenoStent.
Is VenoStent a funded company?
VenoStent is a funded company, having raised a total of $23.36M across 11 funding rounds to date. The company's 1st funding round was a Grant of $3.6M, raised on Mar 07, 2018.
What does VenoStent do?
VenoStent was founded in 2017 and is based in Nashville, United States. The company operates in the medical device sector, focusing on vascular surgery solutions. A shape memory polymer stent, known as SelfWrap, is developed as an external wrap for venous access in hemodialysis patients. Mechanical support is provided to reduce vein collapse and promote vein growth at surgical sites.
Who are the top competitors of VenoStent?
VenoStent's top competitors include Invizius, Redsense Medical and Renal Solutions.
What products or services does VenoStent offer?
VenoStent offers SelfWrap.
Who are VenoStent's investors?
VenoStent has 17 investors. Key investors include NIH, HHS, Norwest Venture Partners, Good Growth Capital, and IAG Capital Partners.